Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

Hematology is a part of drug, which manages the study of blood, blood illnesses and blood-forming organs. Hematology incorporates issues related with white platelets, red platelets, bone marrow, lymph, and platelets. It additionally influences the fluid part of blood known as plasma. Hematology incorporates different IVD advancements, such as blood analysis, stream cytometry, molecular and atomic diagnostics, hemostasis, histology, and cytology. Some of the blood-related infections are weakness, leukemia, myelofibrosis, threatening lymphomas, blood transfusion and bone marrow. Hematology also analyze the weakness, disease, hemophilia, and blood coagulating. The report provides analysis of global hematology diagnostics market for the period 2016-2026, wherein 2018 to 2026 is the forecast period and 2017 is considered as the base year. The global Hematology Diagnostics market is anticipated to grow at considerable CAGR above 5.8% over the forecast period and reach US$ 9.54 Bn by 2026.

Market Dynamics

Rise in frequency of blood disorders, introduction of technologically enhanced automated hematology analyzers, technological advancements and growing awareness among people are some of the fundamental factors which are responsible for the growth of the hematology diagnostics market globally. Huge demand for lab automation and increment in consolidation among market players and diagnostic labs are key factors that are driving the worldwide hematology diagnostics market during the forecast period. Point-Of-Care (POC) hematology tests are easy to understand as they diminish the requirement for user training alongside enabling remote testing. Besides, these tests decrease the turnaround time. Rising adoption of these tests is foreseen to fuel the market growth over the estimated time frame. Expanding number of diagnostic centers and accessibility of advanced instruments are expected to fuel the demand for haematology diagnostics. However, high cost of the automated instruments and lack of awareness among people in developing economies may hamper the growth of the haematology diagnostics market growth.

Market Segmentation

Market by Product

  • Instrument
    • Analyzers
    • Flow Cytometers
    • Others
  • Consumables
  • Reagents
  • Stains
  • Others

Market by Test Type     

  • Blood count
  • Platelet function
  • Hemoglobin
  • Hematocrit

Market by End Use

  • Hospitals
  • Diagnostic Labs
  • Others

Market by Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

The market research study on “Hematology Diagnostics Market (By Product - Instrument [Analyzers, Flow Cytometers, Others], Consumables, Reagents, Stains, Others; By Test Type - Blood Count, Platelet function, Hemoglobin, Hematocrit; By End Use - Hospitals, Diagnostic Labs, Others) - Global Industry Size, Share, Trends and Forecast 2018 - 2026” offers a detailed insights on global hematology diagnosticsmarket entailing insights on its different market segments. Market dynamics with drivers, restraints and opportunities with their impact are provided in the report. The report provides insights on global hematology diagnosticsmarket by product, test type, end use and major geographic regions. The report also covers basic healthcare development policies.

Report Coverage

Market

Hematology Diagnostics Market

Analysis Period

2016– 2026

Historic Data

2016 – 2017

Base Year

2018

Forecast Data

2019 – 2026

Market Stratification

Intervention, Distribution method and Geography

Regional Scope

North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)

Report Coverage

Market Trends, Drivers, Restraints, Porter's Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis

Market Participants

The company profiling of key players in the global Hematology Diagnostics market includes company overview, major business strategies and revenues. The key players of the market are Abbott Laboratories, Ortho Clinical Diagnostics, Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories,  EKF Diagnostics, and Beckman Coulter, Inc.


Cart Summary


1